Skip Ribbon Commands
Skip to main content
Navigate Up
Sign In
John M. Inadomi, MD
Cyrus E. Rubin Professor & Division Head

Dr. Inadomi received an undergraduate degree in biomechanical engineering from M.I.T. and an M.D. from the Unversity of California, San Francisco. He has been on the faculty of the University of New Mexico, the University of Michigan, and the University of California, San Francisco, where he was the Dean M. Craig Endowed Chair in Gastrointestinal Medicine. Dr. Inadomi was recruited to UW Medicine in 2010 to become the fourth head of the Division of Gastroenterology in the Department of Medicine.

Dr. Inadomi is a gastroenterologist with expertise in comparative effectiveness research. He has received funding from the National Institutes of Health (NIH) to evaluate new techniques to decrease mortality from esophageal adenocarcinoma, and to test novel interventions to increase adherence to colorectal cancer screening tests. He is currently the chair of the American Gastroenterological Association Clinical Practice and Quality Management Committee, senior associate editor of the American Journal of Gastroenterology, a member of the American Board of Internal Medicine Subspecialty Board in Gastroenterology, and a standing member of the NIH Health Services, Organization and Delivery Study Section.

Recent Publications
Displaying 20 Most Recent Publications from PubMed

March 2019. Disparities in colorectal cancer screening in New York City: An analysis of the 2014 NYC Community Health Survey. Rastogi N, Xia Y, Inadomi JM, Kwon SC, Trinh-Shevrin C, Liang PS. Cancer Med. 2019 Mar 7. doi: 10.1002/cam4.2084. [Epub ahead of print]

December 2018. Low-Value Colorectal Cancer Screening: Too Much of a Good Thing? Issaka RB, Inadomi JM. JAMA Netw Open. 2018 Dec 7;1(8):e185445. doi: 10.1001/jamanetworkopen.2018.5445.

October 2018. Implications of epigenetic drift in colorectal neoplasia. Luebeck GE, Hazelton WD, Curtius K, Maden SK, Yu M, Carter KT, Burke W, Lampe PD, Li CI, Ulrich CM, Newcomb PA, Westerhoff M, Kaz AM, Luo Y, Inadomi JM, Grady WM. Cancer Res. 2018 Oct 5. pii: canres.1682.2018. doi: 10.1158/0008-5472.CAN-18-1682. [Epub ahead of print]

July 2018. Recent advances in Barrett's esophagus. Inadomi J, Alastal H, Bonavina L, Gross S, Hunt RH, Mashimo H, di Pietro M, Rhee H, Shah M, Tolone S, Wang DH, Xie SH. Ann N Y Acad Sci. 2018 Jul 5. doi: 10.1111/nyas.13909. [Epub ahead of print]

June 2018. Screening and Surveillance for Barrett's Esophagus: Is It Cost-Effective? Inadomi JM, Saxena N. Dig Dis Sci. 2018 Jun 13. doi: 10.1007/s10620-018-5148-7. [Epub ahead of print]

May 2018. Quality indicators for gastrointestinal endoscopy units. ASGE Endoscopy Unit Quality Indicator Taskforce, Day LW, Cohen J, Greenwald D, Petersen BT, Schlossberg NS, Vicari JJ, Calderwood AH, Chapman FJ, Cohen LB, Eisen G, Gerstenberger PD, Hambrick RD 3rd, Inadomi JM, MacIntosh D, Sewell JL, Valori R. VideoGIE. 2017 May 26;2(6):119-140. doi: 10.1016/j.vgie.2017.02.007. eCollection 2017 Jun.

April 2018. Why "More Research Is Needed," Despite Overall Certainty: Women and Colorectal Cancer Screening. Bibbins-Domingo K, Inadomi J. Ann Intern Med. 2018 Apr 24. doi: 10.7326/M18-0963. [Epub ahead of print]

April 2018. Association of Gastric Intestinal Metaplasia and East Asian Ethnicity with the Risk of Gastric Adenocarcinoma in a U.S. Population. Choi AY, Strate LL, Fix MC, Schmidt RA, Ende AR, Yeh MM, Inadomi JM, Hwang JH. Gastrointest Endosc. 2018 Apr;87(4):1023-1028. doi: 10.1016/j.gie.2017.11.010. Epub 2017 Nov 16.

March 2018. Surgical vs Endoscopic Management of T1 Esophageal Adenocarcinoma: a Modeling Decision Analysis. Chu JN, Choi J, Tramontano A, Morse C, Forcione D, Nishioka NS, Abrams JA, Rubenstein JH, Kong CY, Inadomi JM, Hur C. Clin Gastroenterol Hepatol. 2018 Mar;16(3):392-400.e7. doi: 10.1016/j.cgh.2017.10.024. Epub 2017 Nov 24.

February 2018. The Effect of Endoscopic Surveillance in Patients with Barrett's Esophagus: A Systematic Review and Meta-analysis. Codipilly DC, Chandar AK, Singh S, Wani S, Shaheen NJ, Inadomi JM, Chak A, Iyer PG. Gastroenterology. 2018 Feb 16. pii: S0016-5085(18)30225-7. doi: 10.1053/j.gastro.2018.02.022. [Epub ahead of print]

January 2018. Objective Differences in Colonoscopy Technique Between Trainee and Expert Endoscopists Using the Colonoscopy Force Monitor. Ende AR, De Groen P, Balmadrid BL, Hwang JH, Inadomi J, Wojtera T, Egorov V, Sarvazyan N, Korman L. Dig Dis Sci. 2018 Jan;63(1):46-52. doi: 10.1007/s10620-017-4847-9. Epub 2017 Nov 17.

November 2017. Overuse of Repeat Upper Endoscopy in the Veterans Health Administration: A Retrospective Analysis. Rubenstein JH, Pohl H, Adams MA, Kerr E, Holleman R, Vijan S, Dominitz JA, Inadomi JM, Provenzale D, Francis J, Saini SD. Am J Gastroenterol. 2017 Nov;112(11):1678-1685. doi: 10.1038/ajg.2017.192. Epub 2017 Jul 11.

September 2017. Radiofrequency Ablation of Barrett's Esophagus Reduces Esophageal Adenocarcinoma Incidence and Mortality in a Comparative Modeling Analysis. Kroep S, Heberle CR, Curtius K, Kong CY, Lansdorp-Vogelaar I, Ali A, Wolf WA, Shaheen NJ, Spechler SJ, Rubenstein JH, Nishioka NS, Meltzer SJ, Hazelton WD, van Ballegooijen M, Tramontano AC, Gazelle GS, Luebeck EG, Inadomi JM, Hur C. Clin Gastroenterol Hepatol. 2017 Sep;15(9):1471-1474. doi: 10.1016/j.cgh.2016.12.034. Epub 2017 Jan 12.

September 2017. Cost-Effectiveness of Screening Patients with Gastroesophageal Reflux Disease for Barrett's Esophagus With a Minimally Invasive Cell Sampling Device. Heberle CR, Omidvari AH, Ali A, Kroep S, Kong CY, Inadomi JM, Rubenstein JH, Tramontano AC, Dowling EC, Hazelton WD, Luebeck EG, Lansdorp-Vogelaar I, Hur C. Clin Gastroenterol Hepatol. 2017 Sep;15(9):1397-1404.e7. doi: 10.1016/j.cgh.2017.02.017. Epub 2017 Feb 24.

August 2017. Taxonomy for colorectal cancer screening promotion: Lessons from recent randomized controlled trials. Ritvo P, Myers RE, Serenity M, Gupta S, Inadomi JM, Green B, Jerant A, Tinmouth J, Paszat L, Meysam P, Rabeneck L. Prev Med. 2017 Aug;101:229-234. doi: 10.1016/j.ypmed.2016.12.024. Epub 2016 Dec 24.

August 2017. The Impact of a Prior Diagnosis of Barrett's Esophagus on Esophageal Adenocarcinoma Survival. Tramontano AC, Sheehan DF, Yeh JM, Kong CY, Dowling EC, Rubenstein JH, Abrams JA, Inadomi JM, Schrag D, Hur C. Am J Gastroenterol. 2017 Aug;112(8):1256-1264. doi: 10.1038/ajg.2017.82. Epub 2017 Apr 4.

August 2017. Time to Diagnostic Testing After a Positive Colorectal Cancer Screening Test-Reply. Rutter CM, Inadomi JM. JAMA. 2017 Aug 1;318(5):483-484. doi: 10.1001/jama.2017.9316.

July 2017. Development of quality indicators for endoscopic eradication therapies in Barrett's esophagus: the TREAT-BE (Treatment with Resection and Endoscopic Ablation Techniques for Barrett's Esophagus) Consortium. Wani S, Muthusamy VR, Shaheen NJ, Yadlapati R, Wilson R, Abrams JA, Bergman J, Chak A, Chang K, Das A, Dumot J, Edmundowicz SA, Eisen G, Falk GW, Fennerty MB, Gerson L, Ginsberg GG, Grande D, Hall M, Harnke B, Inadomi J, Jankowski J, Lightdale CJ, Makker J, Odze RD, Pech O, Sampliner RE, Spechler S, Triadafilopoulos G, Wallace MB, Wang K, Waxman I, Komanduri S. Gastrointest Endosc. 2017 Jul;86(1):1-17.e3. doi: 10.1016/j.gie.2017.03.010. Epub 2017 May 30.

July 2017. Development of Quality Indicators for Endoscopic Eradication Therapies in Barrett's Esophagus: The TREAT-BE (Treatment With Resection and Endoscopic Ablation Techniques for Barrett's Esophagus) Consortium. Wani S, Muthusamy VR, Shaheen NJ, Yadlapati R, Wilson R, Abrams JA, Bergman J, Chak A, Chang K, Das A, Dumot J, Edmundowicz SA, Eisen G, Falk GW, Fennerty MB, Gerson L, Ginsberg GG, Grande D, Hall M, Harnke B, Inadomi J, Jankowski J, Lightdale CJ, Makker J, Odze RD, Pech O, Sampliner RE, Spechler S, Triadafilopoulos G, Wallace MB, Wang K, Waxman I, Komanduri S. Am J Gastroenterol. 2017 Jul;112(7):1032-1048. doi: 10.1038/ajg.2017.166. Epub 2017 Jun 1.

July 2017. Effectiveness and Cost-Effectiveness of Endoscopic Screening and Surveillance. Saxena N, Inadomi JM. Gastrointest Endosc Clin N Am. 2017 Jul;27(3):397-421. doi: 10.1016/j.giec.2017.02.005. Epub 2017 Apr 4.

June 2017. Increased Post-procedural Non-Gastrointestinal Adverse Events After Outpatient Colonoscopy in High-Risk Patients. Johnson DA, Lieberman D, Inadomi JM, Ladabaum U, Becker RC, Gross SA, Hood KL, Kushins S, Pochapin M, Robertson DJ. Clin Gastroenterol Hepatol. 2017 Jun;15(6):883-891.e9. doi: 10.1016/j.cgh.2016.12.015. Epub 2016 Dec 23.

April 2017. Follow-up of Positive Fecal Test Results: Sooner Is Better, but How Much Better? Rutter CM, Inadomi JM. JAMA. 2017 Apr 25;317(16):1627-1628. doi: 10.1001/jama.2017.3629.

February 2017. Editorial: Endoscopic Sedation: Who, Which, When? Inadomi JM. Am J Gastroenterol. 2017 Feb;112(2):303-305. doi: 10.1038/ajg.2016.557.

January 2017. Screening for Colorectal Neoplasia. Inadomi JM. N Engl J Med. 2017 Jan 12;376(2):149-156. doi: 10.1056/NEJMcp1512286.

January 2017. Introduction of Clinical Practice Update Committee Articles. Friedman LS, Inadomi JM, Kalloo AM, Katzka DA, Kim LS, Koch J, Lieberman D, Lichtenstein GR, Lim JK, Pandolfino JE, Shin AS, Siedler MR. Clin Gastroenterol Hepatol. 2017 Jan;15(1):4. doi: 10.1016/j.cgh.2016.11.011.

December 2016. The impact of medical tourism on colorectal screening among Korean Americans: A community-based cross-sectional study. Ko LK, Taylor VM, Yoon J, Copeland WK, Hwang JH, Lee EJ, Inadomi J. BMC Cancer. 2016 Dec 1;16(1):931.

November 2016. Screening for Colorectal Cancer and Evolving Issues for Physicians and Patients: A Review. Lieberman D, Ladabaum U, Cruz-Correa M, Ginsburg C, Inadomi JM, Kim LS, Giardiello FM, Wender RC. JAMA. 2016 Nov 22;316(20):2135-2145. doi: 10.1001/jama.2016.17418.

October 2016. Racial/Ethnic Disparities in Colorectal Cancer Screening Across Healthcare Systems. Burnett-Hartman AN, Mehta SJ, Zheng Y, Ghai NR, McLerran DF, Chubak J, Quinn VP, Skinner CS, Corley DA, Inadomi JM, Doubeni CA; PROSPR Consortium. Am J Prev Med. 2016 Oct;51(4):e107-15. doi: 10.1016/j.amepre.2016.02.025. Epub 2016 Apr 1.

October 2016. A simple scoring system to assess the need for an endoscopic intervention in suspected upper gastrointestinal bleeding: A prospective cohort study. Horibe M, Kaneko T, Yokogawa N, Yokota T, Okawa O, Nakatani Y, Ogura Y, Matsuzaki J, Iwasaki E, Hosoe N, Masaoka T, Inadomi JM, Suzuki H, Kanai T, Namiki S. Dig Liver Dis. 2016 Oct;48(10):1180-6. doi: 10.1016/j.dld.2016.07.009. Epub 2016 Jul 18.

September 2016. Reply. Wernli KJ, Brenner AT, Rutter CM, Inadomi J. Gastroenterology. 2016 Sep;151(3):564. doi: 10.1053/j.gastro.2016.07.041. Epub 2016 Aug 3.

Contact Info

Fellowship in Gastroenterology, University of California, San Francisco

Residency in Internal Medicine, University of California, San Francisco

MD, University of California, San Francisco

Undergraduate Education, S.B., Mechanical Engineering, Massachusetts Institute of Technology

©2016-2018 University of Washington Division of Gastroenterology
1959 NE Pacific St., Box 356424, Seattle, WA 98195-6424
Contact Us | Privacy | Terms | Copyright & Disclaimer